Target intelligence / Profile preview

Human immunodeficiency virus type 1 p24 Gag capsid protein (HIV-1 p24 (CA))

Target
HIV-1 p24 (CA)
Molecular classification
Viral structural protein, Capsid protein, Member of retroviral polyprotein domain (Gag family)
01

Overview

The HIV-1 p24 Gag protein (also known as capsid protein, CA) is a 24 kDa viral structural protein encoded by the HIV-1 gag gene. It forms the core shell of the HIV virion and is essential for viral assembly, maturation, RNA encapsidation, and successful replication in host cells. p24 interacts with host factors such as cyclophilin A and IP6, which are crucial for capsid stabilization, nuclear import, and infectivity. As a highly conserved and immunogenic protein, p24 serves as a diagnostic marker for HIV infection and is a key target in vaccine and antiretroviral drug research, particularly for maturation inhibitors. Its sequence variability facilitates viral evasion of cell-mediated immunity, presenting challenges for both therapy and vaccine design.

Other names
p24 (capsid protein)CA (capsid protein)HIV-1 capsid proteinGag p24HIV-1 CA protein
02

Mechanism of action

Maturation inhibition: Drugs like Bevirimat and PF-96 block the CA-SP1 cleavage, arresting viral maturation and rendering virions non-infectious. Immune recognition: Vaccines or therapies targeting p24 aim to elicit CTL responses or antibody production to clear infected cells or virions.

03

Biological functions

Capsid formation: forms the core shell of HIV particles, maintaining structural integrityViral assembly and maturation: major component in assembly of viral particles and regulates maturation processInteraction with host cell factors: binds cyclophilin A, nucleoporins, and inositol hexaphosphate (IP6), crucial for nuclear import and stabilizationEncapsulation of viral RNA: essential for packaging viral genome and core proteinsFacilitates release of virions: involved in the late stages of the HIV lifecycle, including budding from host cells
04

Disease associations

Infection: central to HIV-1 infectivity and replication, pivotal in acquired immunodeficiency syndrome (AIDS)Immune evasion: subject to mutations that enable cytotoxic T lymphocyte (CTL) escape and therapy resistanceBiomarker in HIV/AIDS: used for diagnostic detection of HIV-1 infection (historically, p24 antigen test)
05

Safety considerations

Natural resistance: Polymorphisms (e.g., V370A in SP1) confer resistance to maturation inhibitors such as BevirimatCTL escape: High mutation rate in CTL epitopes leads to immune evasionRapid clearance: p24 antigen is rapidly lost from circulation in chronic infection, limiting diagnostic window
06

Interacting drugs

Maturation inhibitors: Bevirimat, PF-96 (target the CA-SP1 cleavage site to interfere with maturation and assembly)

1 more in the full profile.

07

Biomarkers

p24 antigen: detected in blood for HIV screening, especially before seroconversion; its presence marks acute HIV-1 infection

Beyond the preview

Go deeper on Human immunodeficiency virus type 1 p24 Gag capsid protein (HIV-1 p24 (CA)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human immunodeficiency virus type 1 p24 Gag capsid protein (HIV-1 p24 (CA)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call